Insider filing · VRCA

Jayson Rieger bought $400K of Verrica Pharmaceuticals (VRCA)

Executed Nov 25 2025, disclosed Nov 26 2025, the same day.

Over the 21 trading sessions from the disclosed entry session (Nov 25 2025), the stock returned +73.2% (delay-adjusted); from the execution session (Nov 25 2025), +73.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

JR Jayson Rieger CEO and President profile →

Jayson Rieger (CEO and President) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in VRCA. Across 1 priced purchase filing, the average 21-session return was +73.2% from execution and +73.2% from disclosure (delay-adjusted; derived). The largest single filing was $400K of VRCA (94,311 sh × $4.24, as filed), executed Nov 25 2025.

VRCA VRCA VRCA · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→